Flecainide vs amiodarone to treat fast heart rhythm in ER
Treatments studied
Part of Heart & circulation clinical trials.
This trial compares two medicines—flecainide and amiodarone—to help restore normal rhythm during an emergency visit for paroxysmal atrial fibrillation (a-fib). It’s aimed at people who also have coronary artery disease but no ongoing (residual) heart ischemia, and who have enough heart pumping strength.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 85 years old
- Have paroxysmal atrial fibrillation on an ECG (a-fib comes and goes)
- Come to the emergency department within 48 hours of a-fib starting, or within 48 hours to 7 days if you’ve been on blood thinners for at least 30 days
- Have coronary artery disease but no residual ischemia (not ongoing blockage causing reduced blood flow)
- Have heart pumping strength (ejection fraction) above 35% and be able to sign consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether the medication flecainide can reduce frequent extra heartbeats (called PVCs) that come from normal heart tissue, and may help prevent or reverse heart muscle problems caused by these extra beats.
This study tests if flecainide, a heart rhythm drug, is safe for people with both stable coronary artery disease and atrial fibrillation. It aims to help control irregular heartbeats without increasing risks.
This trial tests two different ways of taking amiodarone (a heart rhythm medicine) to keep your heart in a normal rhythm after a procedure called electrical cardioversion. It's designed for people with persistent atrial fibrillation (a fast, irregular heartbeat lasting at least 7 days).
This trial compares two common heart medicines (verapamil and metoprolol) to see which works better for people with a fast, irregular heartbeat called atrial fibrillation. If you come to the Emergency Department with a heart rate of 110 or more and are stable, you may be able to join.
This trial is testing whether giving amiodarone (a heart-rhythm medicine) before an electrical cardioversion can help restore normal heart rhythm better in people with persistent atrial fibrillation. The goal is to see if the medicine makes the procedure more likely to succeed and reduces the chance of the irregular rhythm returning.
This trial studies whether a short course of amiodarone started right after heart surgery can reduce problems from new-onset atrial fibrillation (a common fast heart rhythm) or flutter. It may help some patients avoid ongoing rhythm issues and improve recovery soon after discharge.
Hear when a new Atrial Fibrillation Paroxysmal trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.